IGF2BP2 and glioblastoma: In this study, we identified IGF2BP2 as a potential target to prevent the chemoresistance of GBM, as the evidence indicated that IGF2BP2 promoted etoposide resistance in GBM through the DANCR/PID1/FOXO1 axis.